ICSR Data Quality of Coding: Products, Adverse Events and Medication Errors - Pharmacovigilance 2020
ICSR Data Quality of Coding: Products, Adverse Events and Medication Errors - Pharmacovigilance 2020
|
Loading...
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

ICSR Data Quality of Coding: Products, Adverse Events and Medication Errors - Pharmacovigilance 2020

ICSR Data Quality of Coding: Products, Adverse Events and Medication Errors - Pharmacovigilance 2020

|
Quality of ICSRs

Quality of ICSRs

|
Data Quality of Coding medical Products-Adverse Events-Medication Errors on suspected poor quality

Data Quality of Coding medical Products-Adverse Events-Medication Errors on suspected poor quality

|
FDA Adverse Event Reporting System (FAERS) Overview - Pharmacovigilance 2020

FDA Adverse Event Reporting System (FAERS) Overview - Pharmacovigilance 2020

|
Electronic Submission of Adverse Event Reports to FAERS using ICH E2B(R3) Standards - Oct. 11, 2019

Electronic Submission of Adverse Event Reports to FAERS using ICH E2B(R3) Standards - Oct. 11, 2019

|
Questions and Discussion – Pharmacovigilance 2020

Questions and Discussion – Pharmacovigilance 2020

|
FDA Drug Topics: Reporting and Public Viewing of Individual Case Safety Reports (ICSRs) May 24, 2022

FDA Drug Topics: Reporting and Public Viewing of Individual Case Safety Reports (ICSRs) May 24, 2022

|
Designing User Interfaces to Prevent Medication Errors – Pharmacovigilance 2020

Designing User Interfaces to Prevent Medication Errors – Pharmacovigilance 2020

|
Common CMC (Quality) Issues and How to Avoid Them Part II (13of16) Generic Drugs Forum 2020

Common CMC (Quality) Issues and How to Avoid Them Part II (13of16) Generic Drugs Forum 2020

|
Preventing Medication Errors: Lessons Learned from Postmarket Safety Surveillance– Pharmacovigilance

Preventing Medication Errors: Lessons Learned from Postmarket Safety Surveillance– Pharmacovigilance

|
Combination Products: Reporting Device Information and Malfunctions - Pharmacovigilance 2020

Combination Products: Reporting Device Information and Malfunctions - Pharmacovigilance 2020

|
Keynote – Pharmacovigilance and Risk Management Conference 2020

Keynote – Pharmacovigilance and Risk Management Conference 2020

|
Best Practices for Proprietary Name Design – Pharmacovigilance 2020

Best Practices for Proprietary Name Design – Pharmacovigilance 2020

|
FDA's Sentinel Initiative - Pharmacovigilance 2020

FDA's Sentinel Initiative - Pharmacovigilance 2020

|
What Have We Learned Through Medication Error Reporting?

What Have We Learned Through Medication Error Reporting?

|
Live Demo of the FDA Adverse Events Reporting System (14/14) REdI 2017

Live Demo of the FDA Adverse Events Reporting System (14/14) REdI 2017

|
Evaluating and Investigating Drug Safety Signals with Public Databases

Evaluating and Investigating Drug Safety Signals with Public Databases

|
Pre-ANDA review: Office of Pharmaceutical Quality (OPQ) (4of39) Complex Generics 2018

Pre-ANDA review: Office of Pharmaceutical Quality (OPQ) (4of39) Complex Generics 2018

|
Advanced Drug Safety Program & Pharmacovigilance Career- An Interactive Webinar 2022

Advanced Drug Safety Program & Pharmacovigilance Career- An Interactive Webinar 2022

|
Process for Reviewing Nonproprietary Name Suffix for Biological Products – Pharmacovigilance 2020

Process for Reviewing Nonproprietary Name Suffix for Biological Products – Pharmacovigilance 2020

|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa